Osteoradionecrosis in cancer patients: The evidence base for treatment-dependent frequency, current management strategies, and future studies

Supportive Care in Cancer

Volumn 18, Issue 8, 2010, Pages 1089-1098

  Peterson, Douglas E ^a,b   Doerr, Wolfgang ^c,d   Hovan, Allan ^e   Pinto, Andres ^f   Saunders, Debbie ^g   Elting, Linda S ^h   Spijkervet, Fred K L ⁱ   Brennan, Michael T ^j  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g SUDBURY REGIONAL HOSPITAL   (Canada)

^h UNIVERSITY OF TEXAS   (United States)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^j CAROLINAS MEDICAL CENTER   (United States)

more..

Author keywords

Cancer; Head and neck radiation; Osteoradionecrosis

Indexed keywords

ALPHA TOCOPHEROL; PENTOXIFYLLINE;

BONE NECROSIS; BONE TRANSPLANTATION; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DRUG EFFICACY; HEAD AND NECK CANCER; HEALTH CARE COST; HUMAN; HYPERBARIC OXYGEN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; PATIENT CARE PLANNING; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW;

COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; HEAD AND NECK NEOPLASMS; HEALTH CARE COSTS; HUMANS; OSTEORADIONECROSIS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; QUALITY OF LIFE; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 77956472353     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-010-0898-6     Document Type: Review

References (53)

1. Katsura K, Sasai K, Sato K, Saito M, Hoshina H, Hayashi T (2008) Relationship between oral health status and development of osteoradionecrosis of the mandible: a retrospective longitudinal study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105:731-738
2. Reuther T, Schuster T, Mende U, Kubler A (2003) Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients-a report of a thirty year retrospective review. Int J Oral Maxillofac Surg 32:289-295
3. National Institutes of Health (1990) Consensus development conference on oral complications of cancer therapies: diagnosis, prevention, and treatment. Bethesda, Maryland, April 17-19, 1989. NCI Monogr 9:1-184
4. National Institutes of Health (2009) Oral complications of emerging cancer therapies. Bethesda, MD USA, April 14-15, 2009 (Primary funding provided by National Institutes of Health, Bethesda, MD, USA)
5. Brennan MT, Elting LS, Spijkervet FK (2010) Systematic reviews of oral complications from cancer therapies, Oral Care Study Group, MASCC/ISOO: methodology and quality of the literature. Supp Care Cancer. doi:10.1007/s00520-010-0856-3
6. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100 (9 Suppl): 1995-2025
7. Berard A, Bravo G (1998) Combining studies using effect sizes and quality scores: application to bone loss in postmenopausal women. J Clin Epidemiol 51:801-807
8. Efron B (1993) An introduction to the bootstrap. Chapman and Hall, New York City
9. Miura M, Takeda M, Sasaki T, Inoue T, Nakayama T, Fukuda H, Hoshi A, Hoshina M, Shibuya H (1998) Factors affecting mandibular complications in low dose rate brachytherapy for oral tongue carcinoma with special reference to spacer. Int J Radiat Oncol Biol Phys 41:763-770
10. Marx RE, Johnson RP, Kline SN (1985) Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc 111:49-54
11. Vudiniabola S, Pirone C, Williamson J, Goss AN (1999) Hyperbaric oxygen in the prevention of osteoradionecrosis of the jaws. Aust Dent J 44:243-247
12. Sulaiman F, Huryn JM, Zlotolow IM (2003) Dental extractions in the irradiated head and neck patient: a retrospective analysis of Memorial Sloan-Kettering Cancer Center protocols, criteria, and end results. J Oral Maxillofac Surg 61:1123-1131
13. Adkinson C, Anderson T, Chavez J, Collier R, MacLeod S, Nicholson C, Odland R, Vellis P (2005) Hyperbaric oxygen therapy: a meeting place for medicine and dentistry. Minn Med 88:42-45
14. Marx RE, Johnson RP (1988) Problem wounds in oral and maxillofacial surgery: the role of hyperbaric oxygenation. In: Davis JC, Hunt TK (eds) Problem wounds-the role of oxygen. Elsevier, New York, pp 65-128
15. Notani K, Yamazaki Y, Kitada H, Sakakibara N, Fukuda H, Omori K, Nakamura M (2003) Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy. Head Neck 25:181-186
16. Jisander S, Grenthe B, Salemark L (1999) Treatment of mandibular osteoradionecrosis by cancellous bone grafting. J Oral Maxillofac Surg 57:936-942, discussion 942-943
17. David LA, Sandor GK, Evans AW, Brown DH (2001) Hyperbaric oxygen therapy and mandibular osteoradionecrosis: a retrospective study and analysis of treatment outcomes. J Can Dent Assoc 67:384
18. Maier A, Gaggl A, Klemen H, Santler G, Anegg U, Fell B, Karcher H, Smolle-Juttner FM, Friehs GB (2000) Review of severe osteoradionecrosis treated by surgery alone or surgery with postoperative hyperbaric oxygenation. Br J Oral Maxillofac Surg 38:173-176
19. Annane D, Depondt J, Aubert P, Villart M, Gehanno P, Gajdos P, Chevret S (2004) Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group. J Clin Oncol 22:4893-4900
20. Aitasalo K, Niinikoski J, Grenman R, Virolainen E (1998) A modified protocol for early treatment of osteomyelitis and osteoradionecrosis of the mandible. Head Neck 20:411-417
21. Delanian S, Depondt J, Lefaix JL (2005) Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial. Head Neck 27:114-123
22. Militsakh ON, Wallace DI, Kriet JD, Tsue TT, Girod DA (2005) The role of the osteocutaneous radial forearm free flap in the treatment of mandibular osteoradionecrosis. Otolaryngol Head Neck Surg 133:80-83
23. Claus F, Duthoy W, Boterberg T, De Gersem W, Huys J, Vermeersch H, De Neve W (2002) Intensity modulated radiation therapy for oropharyngeal and oral cavity tumors: clinical use and experience. Oral Oncol 38:597-604
24. van den Broek GB, Balm AJ, van den Brekel MW, Hauptmann M, Schornagel JH, Rasch CR (2006) Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiation for head and neck cancer. Radiother Oncol 81:143-150
25. Studer G, Studer SP, Zwahlen RA, Huguenin P, Gratz KW, Lutolf UM, Glanzmann C (2006) Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT). Strahlenther Onkol 182:283-288
26. Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Malyapa RS, Werning JW, Lansford CD, Villaret DB (2006) Definitive radiotherapy for tonsillar squamous cell carcinoma. Am J Clin Oncol 29:290-297
27. Ryu JK, Stern RL, Robinson MG, Bowers MK, Kubo HD, Donald PJ, Rosenthal SA, Fu KK (1995) Mandibular reconstruction using a titanium plate: the impact of radiation therapy on plate preservation. Int J Radiat Oncol Biol Phys 32:627-634
28. Leborgne F, Leborgne JH, Zubizarreta E, Mezzera J (2002) Cesium-137 needle brachytherapy boosts after external beam irradiation for locally advanced carcinoma of the tongue and floor of the mouth. Brachytherapy 1:126-130
29. Allal AS, Bieri S, Miralbell R, Marchal F, Lehmann W, Kurtz JM (1997) Feasibility and outcome of a progressively accelerated concomitant boost radiotherapy schedule for head and neck carcinomas. Int J Radiat Oncol Biol Phys 38:685-689
30. Toljanic JA, Ali M, Haraf DJ, Vokes EE, Moran WJ, Graham L (1998) Osteoradionecrosis of the jaws as a risk factor in radiotherapy: a report of an eight-year retrospective review. Oncol Rep 5:345-349
31. Grabenbauer GG, Rodel C, Brunner T, Schulze-Mosgau S, Strnad V, Muller RG, Iro H, Sauer R (2001) Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997. Strahlenther Onkol 177:338-344
32. Takacsi-Nagy Z, Polgar C, Oberna F, Somogyi A, Major T, Remenar E, Fodor J, Kasler M, Nemeth G (2004) Interstitial highdose-rate brachytherapy in the treatment of base of tongue carcinoma. Strahlenther Onkol 180:768-775
33. Abitbol A, Abdel-Wahab M, Lewin A, Troner M, Rodrigues MA, Hamilton-Nelson KL, Markoe A (2002) Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol. Int J Radiat Oncol Biol Phys 53:942-947
34. Umeda M, Komatsubara H, Nishimatsu N, Yokoo S, Shibuya Y, Komori T (2000) High-dose rate interstitial brachytherapy for stage I-II tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90:667-670
35. Pernot M, Luporsi E, Hoffstetter S, Peiffert D, Aletti P, Marchal C, Kozminski P, Noel A, Bey P (1997) Complications following definitive irradiation for cancers of the oral cavity and the oropharynx (in a series of 1134 patients). Int J Radiat Oncol Biol Phys 37:577-585
36. De Crevoisier R, Domenge C, Wibault P, Koscielny S, Lusinchi A, Janot F, Bobin S, Luboinski B, Eschwege F, Bourhis J (2001) Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. Cancer 91:2071-2076
37. Carl W, Ikner C (1998) Dental extractions after radiation therapy in the head and neck area and hard tissue replacement (HTR) therapy: a preliminary study. J Prosthet Dent 79:317-322
38. Hehr T, Classen J, Welz S, Ganswindt U, Scheithauer H, Koitschev A, Bamberg M, Budach W (2006) Hyperfractionated, accelerated chemoradiation with concurrent mitomycin-C and cisplatin in locally advanced head and neck cancer, a phase I/II study. Radiother Oncol 80:33-38
39. Withers HR, Peters LJ, Taylor JM, Owen JB, Morrison WH, Schultheiss TE, Keane T, O'Sullivan B, van Dyk J, Gupta N et al (1995) Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology. Int J Radiat Oncol Biol Phys 33:563-568
40. Le Scodan R, Pommier P, Ardiet JM, Montbarbon X, Malet C, Favrel V, Zrounba P, Poupart M, Ceruse P, Ferlay C, Clippe S (2005) Exclusive brachytherapy for T1 and T2 squamous cell carcinomas of the velotonsillar area: results in 44 patients. Int J Radiat Oncol Biol Phys 63:441-448
41. Skladowski K, Maciejewski B, Golen M, Tarnawski R, Slosarek K, Suwinski R, Sygula M, Wygoda A (2006) Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial. Int J Radiat Oncol Biol Phys 66:706-713
42. Huguenin P, Glanzmann C, Taussky D, Lutolf UM, Schmid S, Moe K (1998) Hyperfractionated radiotherapy and simultaneous cisplatin for stage-III and-IV carcinomas of the head and neck. Long-term results including functional outcome. Strahlenther Onkol 174:397-402
43. Olver IN, Hughes PG, Smith JG, Narayan K, Bishop JF (1996) Concurrent radiotherapy and continuous ambulatory infusion 5-fluorouracil in advanced head and neck cancer. Eur J Cancer 32 A: 249-254
44. Arias F, Dominguez MA, Illarramendi JJ, Martinez E, Tejedor M, Dominguez S, Duenas M, Villafranca E, Elcarte F, Miqueliz S et al (1995) Split hyperfractionated accelerated radiation therapy and concomitant cisplatin for locally advanced head and neck carcinomas: a preliminary report. Int J Radiat Oncol Biol Phys 33:675-682
45. Fujita M, Hirokawa Y, Kashiwado K, Akagi Y, Kashimoto K, Kiriu H, Ohtani K, Wada T (1996) An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue. Int J Radiat Oncol Biol Phys 34:333-339
46. Langendijk JA, Kasperts N, Leemans CR, Doornaert P, Slotman BJ (2006) A phase II study of primary reirradiation in squamous cell carcinoma of head and neck. Radiother Oncol 78:306-312
47. Eisen MD, Weinstein GS, Chalian A, Machtay M, Kent K, Coia LR, Weber RS (2000) Morbidity after midline mandibulotomy and radiation therapy. Am J Otolaryngol 21:312-317
48. Tong AC, Leung AC, Cheng JC, Sham J (1999) Incidence of complicated healing and osteoradionecrosis following tooth extraction in patients receiving radiotherapy for treatment of nasopharyngeal carcinoma. Aust Dent J 44:187-194
49. Gibbs IC, Le QT, Shah RD, Terris DJ, Fee WE, Goffinet DR (2003) Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers. Int J Radiat Oncol Biol Phys 57:489-494
50. Maguire PD, Meyerson MB, Neal CR, Hamann MS, Bost AL, Anagnost JW, Ungaro PC, Pollock HD, McMurray JE, Wilson EP, Kotwall CA (2004) Toxic cure: hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for stage III and IVA head-and-neck cancer in the community. Int J Radiat Oncol Biol Phys 58:698-704
51. Oh HK, Chambers MS, Garden AS, Wong PF, Martin JW (2004) Risk of osteoradionecrosis after extraction of impacted third molars in irradiated head and neck cancer patients. J Oral Maxillofac Surg 62:139-144
52. Medina JA, Rueda A, de Pasos AS, Contreras J, Cobo M, Moreno P, Benavides M, Villanueva A, Alba E (2006) A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas. Radiother Oncol 79:34-38
53. Wadsley JC, Patel M, Tomlins CD, Gildersleve JQ (2003) Iridium-192 implantation for T1 and T2a carcinoma of the tongue and floor of mouth: retrospective study of the results of treatment at the Royal Berkshire Hospital. Br J Radiol 76:414-417